194 related articles for article (PubMed ID: 24211824)
1. Role of hemostatic factors on the risk of venous thrombosis in people with impaired kidney function.
Ocak G; Vossen CY; Lijfering WM; Verduijn M; Dekker FW; Rosendaal FR; Cannegieter SC
Circulation; 2014 Feb; 129(6):683-91. PubMed ID: 24211824
[TBL] [Abstract][Full Text] [Related]
2. Determinants of impaired renal and vascular function are associated with elevated levels of procoagulant factors in the general population.
Dekkers IA; de Mutsert R; de Vries APJ; Rosendaal FR; Cannegieter SC; Jukema JW; le Cessie S; Rabelink TJ; Lamb HJ; Lijfering WM
J Thromb Haemost; 2018 Mar; 16(3):519-528. PubMed ID: 29285859
[TBL] [Abstract][Full Text] [Related]
3. Impact of factor VIII and von Willebrand factor plasma levels on cerebral venous and sinus thrombosis: are they independent risk factors?
Shahsavarzadeh T; Javanmard SH; Saadatnia M
Eur Neurol; 2011; 66(4):243-6. PubMed ID: 21967990
[TBL] [Abstract][Full Text] [Related]
4. High levels of coagulation factors and venous thrombosis risk: strongest association for factor VIII and von Willebrand factor.
Rietveld IM; Lijfering WM; le Cessie S; Bos MHA; Rosendaal FR; Reitsma PH; Cannegieter SC
J Thromb Haemost; 2019 Jan; 17(1):99-109. PubMed ID: 30471183
[TBL] [Abstract][Full Text] [Related]
5. High levels of factor VIII and risk of extra-hepatic portal vein obstruction.
Martinelli I; Primignani M; Aghemo A; Reati R; Bucciarelli P; Fabris F; Battaglioli T; Dell'Era A; Mannucci PM
J Hepatol; 2009 May; 50(5):916-22. PubMed ID: 19304336
[TBL] [Abstract][Full Text] [Related]
6. Levels of prolactin in relation to coagulation factors and risk of venous thrombosis. Results of a large population-based case-control study (MEGA-study).
Stuijver DJ; Debeij J; van Zaane B; Dekkers OM; Smit JW; Büller HR; Rosendaal FR; Gerdes VE; Cannegieter SC
Thromb Haemost; 2012 Sep; 108(3):499-507. PubMed ID: 22782187
[TBL] [Abstract][Full Text] [Related]
7. Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk.
Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Doggen CJ
Br J Haematol; 2010 Apr; 149(1):118-23. PubMed ID: 20096009
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of factor VIII and subsequent risk of all-cause mortality: results from the MEGA follow-up study.
Yap ES; Timp JF; Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Cannegieter SC; Lijfering WM
J Thromb Haemost; 2015 Oct; 13(10):1833-42. PubMed ID: 26264493
[TBL] [Abstract][Full Text] [Related]
9. von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis.
Nossent AY; VAN Marion V; VAN Tilburg NH; Rosendaal FR; Bertina RM; VAN Mourik JA; Eikenboom HC
J Thromb Haemost; 2006 Dec; 4(12):2556-62. PubMed ID: 17059421
[TBL] [Abstract][Full Text] [Related]
10. Influence of factor VIII/von Willebrand complex on the activated protein C-resistance phenotype and on the risk for venous thromboembolism in heterozygous carriers of the factor V Leiden mutation.
De Mitrio V; Marino R; Scaraggi FA; Di Bari L; Giannoccaro F; Petronelli M; Ranieri P; Tannoia N; Schiraldi O
Blood Coagul Fibrinolysis; 1999 Oct; 10(7):409-16. PubMed ID: 10695766
[TBL] [Abstract][Full Text] [Related]
11. High levels of coagulation factor XI as a risk factor for venous thrombosis.
Meijers JC; Tekelenburg WL; Bouma BN; Bertina RM; Rosendaal FR
N Engl J Med; 2000 Mar; 342(10):696-701. PubMed ID: 10706899
[TBL] [Abstract][Full Text] [Related]
12. ABO blood group genotypes, plasma von Willebrand factor levels and loading of von Willebrand factor with A and B antigens.
Morelli VM; de Visser MC; van Tilburg NH; Vos HL; Eikenboom JC; Rosendaal FR; Bertina RM
Thromb Haemost; 2007 Apr; 97(4):534-41. PubMed ID: 17393014
[TBL] [Abstract][Full Text] [Related]
13. Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism.
Mello TB; Siqueira LH; Montavão SA; Ozello MC; Annichino-Bizzacchi JM
Thromb Res; 2008; 121(5):625-9. PubMed ID: 17889283
[TBL] [Abstract][Full Text] [Related]
14. Portal vein thrombosis and high factor VIII in Turner syndrome.
Kopacek Zilz C; Keller Brenner J; Elnecave RH
Horm Res; 2006; 66(2):89-93. PubMed ID: 16735794
[TBL] [Abstract][Full Text] [Related]
15. von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis.
Martinelli I
Semin Hematol; 2005 Jan; 42(1):49-55. PubMed ID: 15662616
[TBL] [Abstract][Full Text] [Related]
16. [High concentration of coagulation factor VIII as a risk factor for thrombosis].
Kamphuisen PW; Eikenboom HC; Rosendaal FR; Bertina RM
Ned Tijdschr Geneeskd; 2001 Nov; 145(46):2213-7. PubMed ID: 11757243
[TBL] [Abstract][Full Text] [Related]
17. Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.
Kamphuisen PW; Eikenboom JC; Vos HL; Pablo R; Sturk A; Bertina RM; Rosendaal FR
Thromb Haemost; 1999 May; 81(5):680-3. PubMed ID: 10365736
[TBL] [Abstract][Full Text] [Related]
18. Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals.
Schleef M; Strobel E; Dick A; Frank J; Schramm W; Spannagl M
Br J Haematol; 2005 Jan; 128(1):100-7. PubMed ID: 15606555
[TBL] [Abstract][Full Text] [Related]
19. Venous thrombosis, oral contraceptives and high factor VIII levels.
Bloemenkamp KW; Helmerhorst FM; Rosendaal FR; Vandenbroucke JP
Thromb Haemost; 1999 Sep; 82(3):1024-7. PubMed ID: 10494758
[TBL] [Abstract][Full Text] [Related]
20. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study.
Bash LD; Erlinger TP; Coresh J; Marsh-Manzi J; Folsom AR; Astor BC
Am J Kidney Dis; 2009 Apr; 53(4):596-605. PubMed ID: 19110358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
